Literature DB >> 19740338

Osteopontin is not crucial to protective immunity during murine tuberculosis.

Gerritje J W van der Windt1, Catharina W Wieland, Willem J Wiersinga, Sandrine Florquin, Tom van der Poll.   

Abstract

Upon infection with Mycobacterium (M.) tuberculosis, the development of a strong T helper 1 (Th1)-mediated adaptive immune response is considered as being most important for containment of the infection. Osteopontin (OPN) is a phosphorylated glycoprotein that is chemotactic for inflammatory cells and has been implicated in the induction of Th1 responses and granulomatous disease. We tested the hypothesis that OPN facilitates protective immunity during M. tuberculosis infection using wild-type (WT) and OPN knockout (KO) mice in a model of pulmonary tuberculosis. OPN expression was up-regulated in alveolar macrophages and lymphoid cells during M. tuberculosis infection. There were no significant differences in bacterial outgrowth, inflammation or recruitment of lymphocytes, macrophages and polymorphonuclear cells in the lungs after 2 and 5 weeks of infection. However, the numbers of CD4(+) and CD8(+) T cells were reduced in the absence of OPN 5 weeks after infection. Similar concentrations of cytokine were observed in lungs from both WT mice and OPN KO mice; however, there was a trend towards decreased levels of interferon-gamma (IFN-gamma) in OPN KO mice 5 weeks after infection. Despite an unaltered immune response in the early phase of tuberculosis, OPN KO mice had a modest survival advantage. Of note, both pulmonary bacterial loads and lung inflammation were reduced in these mice 31 weeks after infection. These data suggest that OPN is not crucial for protective immunity upon M. tuberculosis infection and during the late phase of tuberculosis may even be detrimental for the host.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740338      PMCID: PMC2753915          DOI: 10.1111/j.1365-2567.2009.03081.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

Review 1.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

Authors:  D T Denhardt; M Noda; A W O'Regan; D Pavlin; J S Berman
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 2.  Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis.

Authors:  Wendy Peters; Joel D Ernst
Journal:  Microbes Infect       Date:  2003-02       Impact factor: 2.700

3.  Abnormal pulmonary granuloma formation in osteopontin-deficient mice.

Authors:  A W O'Regan; J M Hayden; S Body; L Liaw; N Mulligan; M Goetschkes; J S Berman
Journal:  Am J Respir Crit Care Med       Date:  2001-12-15       Impact factor: 21.405

Review 4.  How can immunology contribute to the control of tuberculosis?

Authors:  S H Kaufmann
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

5.  The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.

Authors:  D Chabas; S E Baranzini; D Mitchell; C C Bernard; S R Rittling; D T Denhardt; R A Sobel; C Lock; M Karpuj; R Pedotti; R Heller; J R Oksenberg; L Steinman
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

6.  Role of osteopontin in murine Lyme arthritis and host defense against Borrelia burgdorferi.

Authors:  Melissa R Potter; Susan R Rittling; David T Denhardt; Randall J Roper; John H Weis; Cory Teuscher; Janis J Weis
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis.

Authors:  Jaklien C Leemans; Sandrine Florquin; Mirjam Heikens; Steven T Pals; Ronald van der Neut; Tom Van Der Poll
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis.

Authors:  Yoshinobu Koguchi; Kazuyoshi Kawakami; Kaori Uezu; Kiyoyasu Fukushima; Sigeyuki Kon; Masahiro Maeda; Atsushi Nakamoto; Isoko Owan; Mutsuo Kuba; Norifumi Kudeken; Masato Azuma; Satomi Yara; Takashi Shinzato; Futoshi Higa; Masao Tateyama; Jun-Ichi Kadota; Hiroshi Mukae; Shigeru Kohno; Toshimitsu Uede; Atsushi Saito
Journal:  Am J Respir Crit Care Med       Date:  2003-02-05       Impact factor: 21.405

9.  The roles of soluble osteopontin using osteopontin-transgenic mice in vivo: proliferation of CD4+ T lymphocytes and the enhancement of cell-mediated immune responses.

Authors:  Yasunori Higuchi; Yoichi Tamura; Tomohisa Uchida; Keiko Matsuura; Naoki Hijiya; Shunsuke Yamamoto
Journal:  Pathobiology       Date:  2004       Impact factor: 4.342

10.  CD14 contributes to pulmonary inflammation and mortality during murine tuberculosis.

Authors:  Catharina W Wieland; Gerritje J W van der Windt; W Joost Wiersinga; Sandrine Florquin; Tom van der Poll
Journal:  Immunology       Date:  2008-04-03       Impact factor: 7.397

View more
  2 in total

1.  Osteopontin impairs host defense during established gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis).

Authors:  Gerritje J W van der Windt; W Joost Wiersinga; Catharina W Wieland; Ivo C S I Tjia; Nicholas P Day; Sharon J Peacock; Sandrine Florquin; Tom van der Poll
Journal:  PLoS Negl Trop Dis       Date:  2010-08-31

2.  The association between osteopontin and tuberculosis: A systematic review and meta-analysis.

Authors:  Dongguang Wang; Xiang Tong; Lian Wang; Shijie Zhang; Jizhen Huang; Li Zhang; Hong Fan
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.